deferiprone has been researched along with Benign Paroxysmal Peritonitis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Excerpt | Relevance | Reference |
---|---|---|
"Herein we present a 7-year-old beta-thalassemia major patient who developed severe Henoch-Schönlein purpura (HSP) with renal, pulmonary involvement and invagination while under iron chelation with deferiprone." | 3.74 | Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment. ( Besbas, N; Gücer, S; Gümrük, F; Kale, G; Ozen, S; Unal, S, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Unal, S | 1 |
Gücer, S | 1 |
Kale, G | 1 |
Besbas, N | 1 |
Ozen, S | 1 |
Gümrük, F | 1 |
1 other study available for deferiprone and Benign Paroxysmal Peritonitis
Article | Year |
---|---|
Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment.
Topics: Amino Acid Substitution; beta-Thalassemia; Child; Deferiprone; DNA; Familial Mediterranean Fever; Hu | 2008 |